REGENERON PHARMACEUTICALS | 379.65 / +3.32% |
Date/Time | 03/05 / 17:32 |
Chg. / Chg.(%) | 12.20 / +3.32% |
Bid | - |
Ask | - |
Open | 374.25 |
Previous Close | 367.45 |
High | 382.25 |
Low | 370.50 |
Volume [EUR] | 69,606.45 |
Volume [Units] | 185 |
Price fixings | 33 |
ISIN | US75886F1075 |
Security | REGN |
Exchange | Vienna Global Market |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NASDAQ | 459.8400 | ![]() |
888,093 |
Cboe US | 460.17 | ![]() |
67,428 |
IEX | 460.77 | ![]() |
53,752 |
TradeGate | 386.000 | ![]() |
937 |
Moscow | 34,061.00 | ![]() |
677 |
Frankfurt | 379.2000 | ![]() |
228 |
Vienna Globa.. | 379.65 | ![]() |
185 |
London Inter.. | 449.63 | ![]() |
151 |
Stuttgart | 383.300 | ![]() |
120 |
Xetra | 381.50 | ![]() |
67 |
München | 381.55 | ![]() |
42 |
gettex | 385.750 | ![]() |
29 |
Hamburg | 373.00 | ![]() |
0 |
Hannover | 373.00 | ![]() |
0 |
Düsseldorf | 387.00 | ![]() |
0 |
Berlin | 370.30 | ![]() |
0 |
Lang & Schwa.. | 385.70 | ![]() |
|
Mexico | 9,480.00 | ![]() |
85 |
News
- FDA accepts Dupixent® (dupilumab) for review in children with moderate-to-severe asthma
03/04/2021 / 07:00 - GlobeNewswire - EMA extends use advice for Regeneron COVID mix
02/26/2021 / 12:28 - TeleTrader - Ziopharm Oncology Provides Leadership and Corporate Updates; Reports Fourth Quarter and Full Year 2020 Financial Results
02/25/2021 / 22:05 - GlobeNewswire - Europe closes lower amid recovery uncertainties
02/25/2021 / 17:31 - TeleTrader - Regeneron: COVID cocktail has clear efficacy
02/25/2021 / 14:13 - TeleTrader